Alx Oncology Holdings
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +25.5% | -3.0% | -3.4% | -46.0% | -19.5% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +25.5% | -3.0% | -3.4% | -46.0% | -19.6% | -100.0% | – | +462,863.0% | +2,940.0% | +72.4% | -1.1% | +45.2% | -25.5% | +41.8% | +4.0% | +25.4% | -1.0% | -59.3% | -1.0% | +3.4% | +2.8% | +1.8% | – | – | -9.5% | – | – | – | – | – | |
| – | +25.5% | -3.4% | -3.5% | -46.4% | -18.6% | -100.0% | – | -4,545,554.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -148.6% | – | – | – | – | – | – | |
| – | -2.8% | -39.1% | +204.8% | -43.2% | +100.2% | -30.5% | +127.9% | -18.9% | +13.8% | +62.4% | +14.7% | -18.3% | +56.7% | +9.8% | -14.2% | -1.7% | +19.1% | +55.2% | -8.7% | -24.1% | +9.3% | -23.6% | -11.1% | +1.5% | -24.6% | -3.2% | +1.2% | -22.9% | -3.4% | – | |
| – | +15.5% | +38.1% | +18.1% | +32.9% | +115.3% | +41.3% | +26.8% | -23.3% | +16.7% | +25.1% | +19.1% | +1.3% | -8.2% | +3.7% | -3.8% | +6.0% | -1.9% | +2.9% | -16.9% | -3.1% | +13.7% | -11.3% | +16.2% | +12.0% | -31.3% | -6.6% | +5.6% | -0.3% | -4.2% | – | |
| – | -0.3% | -26.9% | +149.1% | -32.4% | +104.4% | -9.5% | +81.7% | -20.3% | +14.7% | +50.8% | +15.9% | -13.1% | +36.5% | +8.6% | -13.3% | +1.2% | +14.2% | +44.9% | -9.9% | -21.8% | +10.0% | -21.2% | -6.0% | +3.9% | -16.3% | -15.4% | +2.2% | -18.3% | -4.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +923.8% | +1.9% | +3.2% | -33.2% | -98.0% | +0.0% | +33.3% | -25.0% | +0.0% | -33.3% | +0.0% | +123,450.0% | -84.3% | -3.9% | +5.1% | +6.1% | +2.9% | +0.5% | +4.0% | -4.3% | -4.9% | -0.2% | +0.7% | -6.1% | -13.6% | -13.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -11.1% | +0.0% | +12.5% | -55.6% | +400.0% | +75.0% | +420.0% | -84.1% | +6.9% | -41.9% | -216.7% | – | – | – | – | -2,650.0% | – | -130.0% | – | -85.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.